QuiVad

Home / Sweden / Hansa Biopharma AB

Hansa Biopharma AB

Short position disclosed on August 11, 2026.

Follow

Evolution of the disclosed total

0%2%4%6%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 4.82% on March 10, 2025. The shaded band is the year shown above.

January 15, 2019 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
ActusRayPartners Limited0.89%+0.29 ptAugust 7, 2026
GSA Capital Partners LLP0.60%+0.06 ptAugust 6, 2026
Connor Clark & Lunn Investment Management Ltd.0.59%-0.02 ptAugust 11, 2026

On the other side: the funds that hold Hansa Biopharma AB Titelia

History of disclosures

428 disclosures on record for this share.
DateFund% of capitalEnd of publication
October 8, 2021Worldquant LLC0.76%still open
October 8, 2021Capital Fund Management SA0.51%still open
October 7, 2021Marshall Wace LLP0.99%still open
October 5, 2021Marshall Wace LLP1.06%still open
September 30, 2021Worldquant LLC0.61%still open
September 24, 2021Worldquant LLC0.50%still open
September 15, 2021Marshall Wace LLP1.18%still open
September 2, 2021Arrowstreet Capital Limited Partnership0.88%still open
September 1, 2021Marshall Wace LLP1.21%still open
August 27, 2021Marshall Wace LLP1.10%still open
August 27, 2021Citadel Advisors LLC0.00%still open
August 23, 2021Citadel Advisors LLC0.57%still open
August 19, 2021Arrowstreet Capital Limited Partnership0.90%still open
August 18, 2021Marshall Wace LLP1.00%still open
August 18, 2021Worldquant LLC0.00%still open
August 13, 2021Arrowstreet Capital Limited Partnership0.81%still open
August 11, 2021Worldquant LLC0.56%still open
August 10, 2021Citadel Advisors LLC0.69%still open
August 10, 2021Worldquant LLC0.60%still open
August 9, 2021Citadel Advisors LLC0.74%still open
August 5, 2021Marshall Wace LLP0.90%still open
August 5, 2021Citadel Advisors LLC0.86%still open
August 5, 2021Arrowstreet Capital Limited Partnership0.70%still open
August 2, 2021Citadel Advisors LLC0.94%still open
August 2, 2021Marshall Wace LLP0.83%still open
July 29, 2021Citadel Advisors LLC0.85%still open
July 28, 2021Citadel Advisors LLC0.90%still open
July 28, 2021Marshall Wace LLP0.72%still open
July 26, 2021Worldquant LLC0.51%still open
July 22, 2021Citadel Advisors LLC0.80%still open
July 22, 2021PDT Partners LLC0.00%still open
July 21, 2021Arrowstreet Capital Limited Partnership0.68%still open
July 20, 2021Citadel Advisors LLC0.79%still open
July 20, 2021Arrowstreet Capital Limited Partnership0.71%still open
July 20, 2021Marshall Wace LLP0.66%still open
July 19, 2021Citadel Advisors LLC0.82%still open
July 19, 2021Marshall Wace LLP0.70%still open
July 19, 2021PDT Partners LLC0.53%still open
July 16, 2021Citadel Advisors LLC0.98%still open
July 16, 2021Marshall Wace LLP0.68%still open
July 16, 2021PDT Partners LLC0.65%still open
July 15, 2021Citadel Advisors LLC1.03%still open
July 15, 2021PDT Partners LLC0.75%still open
July 15, 2021Marshall Wace LLP0.54%still open
July 12, 2021Arrowstreet Capital Limited Partnership0.69%still open
July 9, 2021Citadel Advisors LLC0.81%still open
July 7, 2021Arrowstreet Capital Limited Partnership0.70%still open
July 2, 2021Citadel Advisors LLC0.70%still open
June 28, 2021Citadel Advisors LLC0.62%still open
June 24, 2021PDT Partners LLC0.00%still open

Other companies sold short in Sweden

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Hansa Biopharma AB, source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/hansa-biopharma-ab?page=5